Tucker: ‘Following The Money’ Of ‘Trans, Inc’ ‘Can’t Even Do Lip Filler In A Convincing Way’

In a recent interview, Daily Caller co-founder Tucker Carlson sat down with policy expert Chris Moritz to discuss the financial incentives behind the growing industry of transgender surgeries and hormone replacement therapies, which Moritz refers to as “Trans, Inc.” According to Moritz, in 2018, the combined sales of these procedures amounted to $2.94 billion, a figure that is expected to reach $7.5 billion by 2030, representing an 8.5 percent annual growth rate. This is a staggering figure, especially considering that there are only approximately 1.6 million transgender adults in the United States, a number that has doubled in the past 10 years.

Moritz also claims that there is no scientific evidence to support the idea that transgenderism is something a person is born with. He argues that there are no studies examining the long-term effects of these procedures and pharmaceutical products, particularly on children. Carlson expresses surprise at this, asking if there are no studies at all. Moritz confirms that there are none.

Throughout his time discussing transgender issues on TV, Carlson has never encountered a detailed description of the surgeries in question. He notes that the details are often omitted in discussions and expresses his reluctance to even search for photographs online. Moritz goes on to describe a procedure called a vaginoplasty, which involves castrating a male-to-female patient, inverting the penis to create a vaginal cavity, and using skin grafting to create female genitalia. Carlson makes a comment about the inadequacy of cosmetic procedures in this country, and Moritz cites a study that found 25% of vaginoplasty patients experienced severe side effects and required hospitalization.

Moritz also mentions mastectomies, which are increasingly being performed on minors. This leads Carlson to make a sarcastic remark about the Western world now being associated with radical ideologies that were previously attributed to Muslim countries. Moritz goes on to reveal that Iran is actually one of the largest centers for sex-reassignment surgery in the world.

Moritz’s research paints a disturbing picture of the financial motivations behind the growing industry of transgender surgeries and hormone replacement therapies. As these procedures become increasingly profitable, it raises questions about whether they are truly in the best interest of the individuals undergoing them, particularly minors.

WATCH

The lack of long-term studies on their efficacy and potential side effects only adds to the concerns. With so much money at stake, it is crucial to continue questioning the ethics and motivations behind these procedures, rather than blindly accepting them as the solution to gender dysphoria.

Send this to a friend